Institutional Perspectives in Cancer: Precision Medicine - Chaired by Andrew McKenzie, PhD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers 

• Andrew McKenzie, PhD | Sarah Cannon Research Institute
• Indira Vadlamani, MD, FCAP, CPE | The Woman’s Hospital of Texas, HCA Houston Healthcare
• Melissa Johnson, MD | Sarah Cannon Research Institute at Tennessee Oncology
• Denise Yardley, MD | Sarah Cannon Research Institute at Tennessee Oncology

Topics

• Best Practices for Biomarker Testing
• Interpreting Molecular Results
• Current and Emerging Lung Cancer Biomarkers
• Current and Emerging Breast Cancer Biomarkers
• Future Direction of Biomarker Testing

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!